Your Cart ( 1 Item )

• An Open-Label Pilot Study to Investigate Safety and Efficacy of Fixed Combination Tazarotene 0.045% and Halobetasol Propionate 0.01% Lotion for the Treatment of Scalp Psoriasis
  November 2021 | Volume 20 | Issue 11 | Original Article | 1191 | Copyright © November 2021
  Elif Ozyurekoglu ^a, Leon H. Kircik MD^a
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs